The year is coming to an end. And what a year it was for Sagitta! We hired great people, built our own lab, had great collaborations, achieved (most of) our development objectives, and solved many unexpected challenges. We expect 2025 to have more of the same, setting our route towards clinical trials for our first indication. Bring it on! 😉
Sagitta Biotech
Biotechnology
Liège, Walloon Region 678 followers
Innovative viral vectors for vaccines, oncology and gene therapy
About us
Sagitta Biotech is a company developping an innovative viral vector to develop efficient vaccines, oncolytic viruses and gene therapy vectors. Our active virosome platform can deliver up to 17kb mRNA (6 genes), and elicit both humoral and cellular reponse. Sagitta is developping its own pipeline of innovative multivalent vaccines (currently in preclinical phases) and oncolytic viruses, and is open to partnering and co-development. In ancient Greece, Sagitta was regarded as the weapon that Hercules used to kill the eagle (Aquila) of Jove that perpetually gnawed Prometheus' liver.
- Website
-
http://www.sagittabiotech.com
External link for Sagitta Biotech
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Liège, Walloon Region
- Type
- Privately Held
- Founded
- 2019
- Specialties
- immunotherapy, cancer, oncolytic virus, checkpoint inhibitors, vaccines, multivalent vaccines, and gene therapy
Locations
-
Primary
Get directions
Avenue Pré Aily, 10
Liège, Walloon Region 4031, BE
Employees at Sagitta Biotech
Updates
-
Sagitta Biotech will take part to the upcoming The World Vaccine Congress. We are looking forward to the very interesting presentation and panel discussions. Do not hesitate to get in touch with our délégates Hélène Gazon or Benjamin DAMIEN. #biotech #vaccines
-
-
Happy to be taking part to #Biowin 's annual dinner, and see once again the dynamism of Wallonia's (and Belgium's) biotech sector
-
-
The Belgian Café at #bio2024. Warm thanks to the Flanders Investment & Trade (FIT) and AWEX USA teams for this great event, celebrating the Belgian Biotech sector as well as Belgian hospitality. #biotech
-
-
If you want to learn about Sagittabiotech 's hybrid viral vector/mRNA technology, meet @benjamindamien on the Belgian booth (nr 4023). We can't make any garantees about Ben's other statements (other that he may indeed carry a badge around his neck). ;-)
Happy to be part of the Belgian delegation at #BIO2024. If you want to learn about #sagittabiotech 's hybrid viral vector/mRNA technology, come and find me at booth 4023. I'm quite easy to spot as 1) I've got a badge with my name around my neck and 2) I'm incredibly handsome. #belgium #biotech #awex #fit #vaccines
-
-
Another day, another congress. This time the anticipated Bio Investment Convention, (well) organized by Bridge2Health. #biotech #fundraising
-
-
Looking forward to all the great talks at the 2024 #knowledgeforgrowth #kfg2024
-
-
Our CEO, Benjamin DAMIEN, is taking part to the "Europe United against Old and New Pandemics" EU conference in Antwerp.
Participating to the "Europe United against Old and New Pandemics" conference in Antwerp. Looking forward to the talks and to play our part in the fight with @SagittaBiotech #vaccines #healthcare #prevention https://lnkd.in/e83uf9NC
Europe united against old and new pandemics (cluster 1), aka Conference on Preparedness
belgian-presidency.consilium.europa.eu
-
Sagitta Biotech's CEO, Benjamin DAMIEN will be at #KFG2024 and will be part of the jury of one of the Elevator Pitch sessions.
I'll be taking part to the congress Knowledge For Growth 2024, and I'm honored to be part of the jury of Flanders' vaccine Elevator Pitch session. See you on May 15th&16th! #kfg2024 #biotech https://lnkd.in/errpCiUh
Home
knowledgeforgrowth.be